Opioid analgesia and opioid-induced adverse effects: a review

AK Paul, CM Smith, M Rahmatullah, V Nissapatorn… - Pharmaceuticals, 2021 - mdpi.com
Opioids are widely used as therapeutic agents against moderate to severe acute and
chronic pain. Still, these classes of analgesic drugs have many potential limitations as they …

State-dependent opioid control of pain

H Fields - Nature reviews neuroscience, 2004 - nature.com
Agonists for the μ-opioid receptor are powerful analgesics and are highly addictive;
however, the contribution of the δ-and κ-opioid and opioid receptor-like receptors to …

Endogenous opioid systems alterations in pain and opioid use disorder

JA Higginbotham, T Markovic, N Massaly… - Frontiers in systems …, 2022 - frontiersin.org
Decades of research advances have established a central role for endogenous opioid
systems in regulating reward processing, mood, motivation, learning and memory …

[HTML][HTML] Biased opioid ligands

A Faouzi, BR Varga, S Majumdar - Molecules, 2020 - mdpi.com
Achieving effective pain management is one of the major challenges associated with
modern day medicine. Opioids, such as morphine, have been the reference treatment for …

Targeting multiple opioid receptors–improved analgesics with reduced side effects?

T Günther, P Dasgupta, A Mann, E Miess… - British journal of …, 2018 - Wiley Online Library
Classical opioid analgesics, including morphine, mediate all of their desired and undesired
effects by specific activation of the μ‐opioid receptor (μ receptor). The use of morphine for …

Delta and kappa opioid receptors as suitable drug targets for pain

TW Vanderah - The Clinical journal of pain, 2010 - journals.lww.com
Similar to μ opioid receptors, κ and δ opioid receptors reside in the periphery, the dorsal root
ganglion, the spinal cord, and in supraspinal regions associated with pain modulation. Both …

Molecular pharmacology of δ-opioid receptors

L Gendron, CM Cahill, M von Zastrow, PW Schiller… - Pharmacological …, 2016 - Elsevier
Opioids are among the most effective analgesics available and are the first choice in the
treatment of acute severe pain. However, partial efficacy, a tendency to produce tolerance …

Knockin mice expressing fluorescent δ-opioid receptors uncover G protein-coupled receptor dynamics in vivo

G Scherrer, P Tryoen-Tóth, D Filliol, A Matifas… - Proceedings of the …, 2006 - pnas.org
The combination of fluorescent genetically encoded proteins with mouse engineering
provides a fascinating means to study dynamic biological processes in mammals. At …

Targeting opioid dysregulation in depression for the development of novel therapeutics

CA Browne, I Lucki - Pharmacology & therapeutics, 2019 - Elsevier
Since the serendipitous discovery of the first class of modern antidepressants in the 1950's,
all pharmacotherapies approved by the Food and Drug Administration for major depressive …

Ligand‐directed signalling within the opioid receptor family

AA Pradhan, ML Smith, BL Kieffer… - British journal of …, 2012 - Wiley Online Library
The classic model of GPCR activation proposed that all agonists induce the same active
receptor conformation. However, research over the last decade has shown that GPCRs exist …